Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing Synaptic Density in Treatment Resistant Depression

NCT03537794 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT03537794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03537794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing Synaptic Density in Treatment Resistant Depression
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Recruiting
Start date
August 22, 2025
Completion date
December 31, 2029
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, treatment resistant depression